Could a gentle brain ZAP help seniors walk better and protect their hearts?
NCT ID NCT07573800
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will test whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can improve cardiovascular and walking outcomes in 36 community-dwelling older adults. Participants will receive either real or sham tDCS, and researchers will measure changes in walking speed, blood pressure, heart rate variability, and physical function. The goal is to explore a new, drug-free way to support healthy aging.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS)
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help older adults maintain heart health and mobility.
- What could go wrong
- This is a very small, early-stage study (36 people) that hasn't started yet. It's testing a concept, not a proven treatment, and results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Able to ambulate independently (with or without assistive device) * Cognitively intact (MoCA score ≥ 24) * PAR-Q Exclusion Criteria: * History of seizures or epilepsy * Implanted metallic or electronic devices (e.g., pacemakers, ICD) * Uncontrolled hypertension (\>180/110 mmHg) * Severe cardiac, pulmonary, neurological, or orthopedic disorders limiting participation * Active skin conditions at electrode sites * Recent hospitalization (\<3 months) * Ongoing hormonal therapy, anticoagulants, or psychotropic medications
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Community-dwelling elderly are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pakistan Railway Hospital
Rawalpindi, Punjab Province, Pakistan